Reducing Heart Failure Risk In People With Diabetes – the STOP HF Midlands Project

Recent data indicate that optimal cardiovascular (CV) risk management negates most of the increased CV risk associated with diabetes mellitus1. However there was a persistent increased risk of heart failure (HF). Recent studies showing the beneficial effect of SGLT2 inhibitors in reducing incident heart failure highlights the need for new ways of identifying those at highest risk of heart failure and personalizing therapeutic interventions to this group2. As the onset of HF is mediated by the development of a cardiomyopathy, the use of natriuretic peptide (NP) screening might highlight those at higher risk.

Source: Journal of Cardiac Failure - November 8, 2019 Category: Cardiology Authors: J Gallagher, S James, C Watson, V Harkins, M Ledwidge, K McDonald Source Type: research